You're reading the free version. Trader adds the live tape and alerts.
Start tracking
APGE Exercise Disclosure
Dambkowski Carl · SEC Form 4 · Filed Aug 7, 2026
Exercise
Calculated transaction value
$94.3K
Dambkowski Carl Chief Medical Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Aug 5, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed 2 days later
APGE daily price context
Close on/before transaction
$134.23
Aug 5, 2026
First close after public filing
$134.65
Aug 10, 2026
Return after filing · so far
+0.31%
Through Sep 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,125 shares @ $22.86
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-092838
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$832.23K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE Current | Exercise | Aug 5, 2026 | $94.3K |
| Apogee Therapeutics, Inc. APGE | Sale | Aug 5, 2026 | $737.93K |
| Apogee Therapeutics, Inc. APGE | Exercise | Aug 5, 2026 | $0 |